Epigenetic Therapy of Cancer

Preclinical Models and Treatment Approaches

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Hematology, Oncology
Cover of the book Epigenetic Therapy of Cancer by , Springer Berlin Heidelberg
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783642384042
Publisher: Springer Berlin Heidelberg Publication: December 12, 2013
Imprint: Springer Language: English
Author:
ISBN: 9783642384042
Publisher: Springer Berlin Heidelberg
Publication: December 12, 2013
Imprint: Springer
Language: English

The growing knowledge about disturbances of epigenetic gene regulation in hematopoietic stem cell disorders is now being translated into treatment approaches that target the epigenetic defects pharmacologically. This book first presents the latest evidence regarding the epigenetic regulation of hematopoietic stem cell differentiation and hemoglobin production. The significance of DNA methylation abnormalities in hematopoietic disorders and of epigenetic disturbances in lung cancer and other solid tumors is then discussed. A major part of the book, however, relates specifically to the translation of basic research and drug development to clinical applications, and in this context both present and future clinical strategies are considered. Individual chapters are devoted to the use of DNA hypomethylating agents and chromatin-modifying agents, and the treatment of hematologic malignancies and solid tumors by means of epigenetic agents is discussed in detail.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The growing knowledge about disturbances of epigenetic gene regulation in hematopoietic stem cell disorders is now being translated into treatment approaches that target the epigenetic defects pharmacologically. This book first presents the latest evidence regarding the epigenetic regulation of hematopoietic stem cell differentiation and hemoglobin production. The significance of DNA methylation abnormalities in hematopoietic disorders and of epigenetic disturbances in lung cancer and other solid tumors is then discussed. A major part of the book, however, relates specifically to the translation of basic research and drug development to clinical applications, and in this context both present and future clinical strategies are considered. Individual chapters are devoted to the use of DNA hypomethylating agents and chromatin-modifying agents, and the treatment of hematologic malignancies and solid tumors by means of epigenetic agents is discussed in detail.

More books from Springer Berlin Heidelberg

Cover of the book Frontiers in Peritoneal Dialysis by
Cover of the book Radiology of the Pancreas by
Cover of the book The Dawn Angiosperms by
Cover of the book Survival of the Fittest by
Cover of the book Meine Zahnarztpraxis – Ökonomie by
Cover of the book Ontologies by
Cover of the book Die Primäre Produktion by
Cover of the book Small-Molecule Inhibitors of Protein-Protein Interactions by
Cover of the book Industrielle Mikrobiologie by
Cover of the book Grundkurs Theoretische Physik 2 by
Cover of the book Deutsches und europäisches Bank- und Kapitalmarktrecht by
Cover of the book Biology of Rhodococcus by
Cover of the book Medizininformatik by
Cover of the book Optimization of Temporal Networks under Uncertainty by
Cover of the book Gene- and Cell-Based Treatment Strategies for the Eye by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy